Ahmedabad, India

Raghvendra Jayantibhai Patel

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Intas Pharmaceuticals Limited. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raghvendra Jayantibhai Patel. Retrieved from https://idiyas.com/inventor/raghvendra-jayantibhai-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raghvendra Jayantibhai Patel: Innovator in Pharmaceutical Chemistry

Introduction

Raghvendra Jayantibhai Patel is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds used in cancer treatment.

Latest Patents

Raghvendra holds a patent for a novel process for the preparation of cabazitaxel and its intermediates. This invention involves a unique method starting from 10-Deacetyl baccatin or its derivatives, which includes the methylation of 7, 10 —OH groups. Additionally, he has developed a process utilizing a chiral bis-lactam linker for the synthesis of cabazitaxel.

Career Highlights

He is currently employed at Intas Pharmaceuticals Limited, where he continues to work on innovative solutions in drug development. His expertise in pharmaceutical processes has positioned him as a valuable asset in the industry.

Collaborations

Raghvendra has collaborated with several professionals in his field, including Mettilda Lourdusamy and Ioan Iosif Radu. These partnerships have enhanced his research and development efforts.

Conclusion

Raghvendra Jayantibhai Patel's work exemplifies the impact of innovation in pharmaceutical chemistry. His contributions, particularly in the synthesis of cabazitaxel, highlight the importance of research in advancing medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…